BLFS Logo

BioLife Solutions, Inc. (BLFS) 

NASDAQ$25
Market Cap
$1.18B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
487 of 924
Rank in Industry
26 of 47

BLFS Insider Trading Activity

BLFS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$5,229,86288100

Related Transactions

Werner SeanChief Technology Officer0$02$5,577$-5,577
Richardson GarrieChief Revenue Officer0$01$77,118$-77,118
Foster Karen A.Chief Quality and Operations0$014$107,269$-107,269
Wichterman TroyChief Financial Officer0$014$266,769$-266,769
Aebersold SarahChief Human Resources Officer0$017$417,983$-417,983
Berard ToddChief Marketing Officer0$017$707,179$-707,179
DE GREEF RODERICKPresident and CEO0$01$1.1M$-1.1M
Mathew Aby J.EVP & Chief Scientific Officer0$022$2.55M$-2.55M

About BioLife Solutions, Inc.

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.

Insider Activity of BioLife Solutions, Inc.

Over the last 12 months, insiders at BioLife Solutions, Inc. have bought $0 and sold $5.23M worth of BioLife Solutions, Inc. stock.

On average, over the past 5 years, insiders at BioLife Solutions, Inc. have bought $64.57M and sold $51.68M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 927,165 shares for transaction amount of $10.37M was made by Casdin Partners Master Fund, L.P. (10 percent owner) on 2023‑10‑19.

List of Insider Buy and Sell Transactions, BioLife Solutions, Inc.

2025-03-12SaleAebersold SarahChief Human Resources Officer
7,324
0.0156%
$26.34$192,914-4.72%
2025-03-11SaleMathew Aby J.EVP & Chief Scientific Officer
1,597
0.0032%
$25.00$39,925-5.86%
2025-03-11SaleFoster Karen A.Chief Quality and Operations
1,331
0.0027%
$25.00$33,275-5.86%
2025-03-11SaleWichterman TroyChief Financial Officer
4,151
0.0083%
$25.00$103,775-5.86%
2025-03-11SaleBerard ToddChief Marketing Officer
1,577
0.0032%
$25.00$39,425-5.86%
2025-03-11SaleAebersold SarahChief Human Resources Officer
1,091
0.0022%
$25.00$27,275-5.86%
2025-03-04SaleWerner SeanChief Technology Officer
88
0.0002%
$24.03$2,115+4.85%
2025-03-03SaleMathew Aby J.EVP & Chief Scientific Officer
425
0.0009%
$25.46$10,821+5.39%
2025-03-03SaleFoster Karen A.Chief Quality and Operations
324
0.0007%
$25.46$8,249+5.39%
2025-03-03SaleWichterman TroyChief Financial Officer
660
0.0015%
$25.46$16,804+5.39%
2025-03-03SaleBerard ToddChief Marketing Officer
424
0.0009%
$25.46$10,795+5.39%
2025-03-03SaleAebersold SarahChief Human Resources Officer
284
0.0006%
$25.46$7,231+5.39%
2025-03-03SaleWerner SeanChief Technology Officer
136
0.0003%
$25.46$3,463+5.39%
2025-02-12SaleMathew Aby J.EVP & Chief Scientific Officer
92
0.0002%
$26.54$2,442-3.17%
2025-02-12SaleFoster Karen A.Chief Quality and Operations
78
0.0002%
$26.54$2,070-3.17%
2025-02-12SaleWichterman TroyChief Financial Officer
159
0.0003%
$26.54$4,220-3.17%
2025-02-12SaleBerard ToddChief Marketing Officer
102
0.0002%
$26.54$2,707-3.17%
2025-02-12SaleAebersold SarahChief Human Resources Officer
53
0.0001%
$26.54$1,407-3.17%
2025-01-06SaleMathew Aby J.EVP & Chief Scientific Officer
404
0.0009%
$27.02$10,916-2.35%
2025-01-06SaleFoster Karen A.Chief Quality and Operations
328
0.0007%
$27.02$8,863-2.35%
Total: 824
*Gray background shows transactions not older than one year

Insider Historical Profitability

7.62%
DE GREEF RODERICKPresident and CEO
414958
0.8829%
$10.37M088
Mathew Aby J.EVP & Chief Scientific Officer
260601
0.5545%
$6.52M1122<0.0001%
Foster Karen A.Chief Quality and Operations
154912
0.3296%
$3.87M073
Wichterman TroyChief Financial Officer
116809
0.2485%
$2.92M044
Richardson GarrieChief Revenue Officer
114773
0.2442%
$2.87M01
Berard ToddChief Marketing Officer
104961
0.2233%
$2.62M091
Aebersold SarahChief Human Resources Officer
51492
0.1096%
$1.29M044
Werner SeanChief Technology Officer
4865
0.0104%
$121,625.0002
Casdin Partners Master Fund, L.P.10 percent owner
8557165
18.2067%
$213.93M140+31.02%
VILLIGER WALTER10 percent owner
3281778
6.9825%
$82.04M1445<0.0001%
Rice Michael
347085
0.7385%
$8.68M2123<0.0001%
Phillips GeraintSVP, Global Operations
65998
0.1404%
$1.65M012
GIRSCHWEILER THOMASdirector
47774
0.1016%
$1.19M27
Schulz MarcusChief Revenue Officer
42097
0.0896%
$1.05M041
DuRoss Amydirector
29443
0.0626%
$736,075.0003
COHEN RAYMOND Wdirector
22763
0.0484%
$569,075.00210<0.0001%
Schick Joseph Cdirector
21449
0.0456%
$536,225.00015
Mathers JamesChief Revenue Officer
19856
0.0422%
$496,400.00048
Hinson Andrew Gdirector
17675
0.0376%
$441,875.00016
RICH ALAN FVice President
8700
0.0185%
$217,500.0040
*Gray background shows insiders who have made transactions during last year

BLFS Institutional Investors: Active Positions

Increased Positions91+42.52%4M+9.86%
Decreased Positions90-42.06%2M-5.11%
New Positions23New2MNew
Sold Out Positions33Sold Out479,613Sold Out
Total Postitions215+0.47%47M+4.75%

BLFS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Casdin Capital, Llc$208,972.0018.93%8.71M00%2024-12-31
Blackrock, Inc.$134,474.0012.18%5.6M+82,261+1.49%2024-12-31
Invesco Ltd.$77,747.007.04%3.24M+36,176+1.13%2024-12-31
Vanguard Group Inc$68,070.006.17%2.84M-12,069-0.42%2024-12-31
Fred Alger Management, Llc$38,261.003.47%1.59M+16,274+1.03%2024-12-31
State Street Corp$35,258.003.19%1.47M+56,762+4.02%2024-12-31
Millennium Management Llc$27,488.002.49%1.15M+377,111+49.09%2024-12-31
William Blair Investment Management, Llc$21,848.001.98%910,348-239,100-20.8%2024-12-31
Cramer Rosenthal Mcglynn Llc$21,738.001.97%905,752-196,907-17.86%2024-12-31
Dimensional Fund Advisors Lp$21,288.001.93%887,008+40,416+4.77%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.